SFJ Pharmaceuticals
-
Malvern’s PhaseBio Signs Co-Development Deal with Pharma Firm, Sees Major Bump in Share Price
Malvern’s PhaseBio saw its shares soar after it signed a financing and co-development deal with California-based SFJ Pharmaceuticals worth up to $120 million, writes Ryan…
Pioneer Partner
Founding Partners
Advertisement
Affiliate Partners
Community Partners
